You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ):吉林突發疫情對總體銷售業務推進不會產生重大影響
格隆匯 03-14 19:34

格隆匯3月14日丨迪瑞醫療(300396.SZ)公佈,公司因吉林省突發新型冠狀病毒肺炎疫情,按照吉林省政府及長春市疫情防控指揮部發布的要求,公司積極響應政府防疫決策部署,組織全體員工全力做好疫情防控工作,為使廣大投資者充分、及時、準確的瞭解本次疫情對公司經營的影響,特進行以下説明:

鑑於本地疫情防控形勢複雜嚴峻,正處於關鍵時期,公司生產的尿液分析、血液分析、核酸提取儀等產品已經應用到部分區域防疫當中。為了積極履行社會責任,公司組織研發、售服及合作伙伴等隨時做好準備,積極提供保障服務。為全力做好新型冠狀病毒肺炎防控工作,全面切斷病毒傳播途徑,按照長春市疫情防控指揮部的要求,公司將採取員工線上辦公為主、單位封閉辦公為輔的方式開展相關工作,竭盡所能降低本次疫情對公司生產經營的影響。

公司國內及國際銷售業務基本完成本地化管理,國內銷售總部設立在北京,各省有分子公司及辦事處,國際市場也完成本地化管理和佈局,截至目前狀態分析判斷,本次疫情對公司總體銷售業務的推進不會產生重大影響。當前疫情尚存不確定性,因員工出行需配合總體防疫部署及要求,公司需要根據員工到崗情況,合理調配產能,存在對新增銷售訂單延後執行確認情況,具體對業績的影響以公吿為準。考慮到近期各地新冠疫情的持續週期,預計吉林突發疫情帶來的影響是短期的,不會給公司長期穩健發展產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account